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The circadian clock is entrained to light by the intrinsically photosensitive retinal ganglion
cells. Loss of these cells in glaucoma, an eye disease with loss of retinal ganglion cells as its
key feature, might thus result in a change in chronotype. We aimed to compare the chrono-
type between glaucoma patients and healthy subjects.
Methods
We sent the Munich ChronoType Questionnaire to 221 glaucoma patients (response rate
81%); controls (primary control group) were primarily their spouses. After exclusion of shift
workers and participants who woke-up due to an alarm clock on days off, 159 glaucoma
patients (88 early, 21 moderate, 23 severe) and 163 controls remained. We calculated
chronotype as the mid-sleep on days off, corrected for workweek accumulated sleep debt
(MSFsc). We compared means and variances between groups using Welch’s tests and F-
tests, respectively. A secondary control group was recruited from participants in a citizen-
science project (n = 17073) who completed an online questionnaire. A resampling method
was applied to enable an age- and gender- matched comparison with the glaucoma
patients.
Results
Compared to the primary control group, glaucoma did not affect the mean MSFsc (controls
3:47; early, moderate, and severe glaucoma 3:40, 3:45, and 3:33, respectively [P = 0.62]).
Chronotype variability seemed to increase with increasing disease severity (severe glau-
coma versus controls: P = 0.023). The mean MSFsc of the secondary control group was
3:50 (95% confidence interval 3:48 to 3:52); significantly later than that of the glaucoma
patients (3:40; P = 0.024). Mean MSFsc did not differ significantly between the control
groups (P = 0.42).
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Conclusions
No clear changes were found in the chronotype as determined by sleep phase in patients
with glaucoma, especially not in early and moderate glaucoma. In severe glaucoma, chrono-
type variability seems to increase, possibly alongside a small advancement.
Introduction
Glaucoma is a chronic and progressive eye disease characterized by loss of retinal ganglion
cells (RGCs) and subsequent visual field loss. Among the different types of RGCs, the
intrinsically photosensitive retinal ganglion cells (ipRGCs) express melanopsin and are held
responsible for nonvisual responses to light, such as the pupillary light reflex [1–3] and the
entrainment of the circadian clock to light [4–8]. Output of the ipRGCs is transmitted to the
suprachiasmatic nucleus, the circadian clock that drives rhythms with a period of approxi-
mately 24 hours in physiology, sleep-wake behaviour, and cognitive performance [9–11]. In
absence of light cues, the circadian system will lose its synchronisation to the Earth’s 24-hour
light/dark cycle, the Zeitgeber [12,13], and this leads to a mismatch between endogenous
rhythms and the sleep-wake cycle. Hence, loss of ipRGC function in glaucoma might result in
circadian misalignment and thus disturb the sleep quality and pattern of glaucoma patients
[14]. Interestingly, the light-induced melatonin suppression, as one of the nonvisual responses
to light, was found to be affected in patients with advanced glaucoma [15–17], and glaucoma
patients often do report a lower sleep quality [18–21]. It is controversial, however, if the latter
is related to RGC damage or to psychological factors [22].
Human circadian phase can be described by means of the chronotype of an individual. The
chronotype of an individual can be defined as the midpoint between sleep onset and wake-up
time on days off [23] corrected for sleep on working days (Mid-Sleep on Free days, Sleep debt
on work days Corrected; MSFsc) [24]. The chronotype as defined by sleep phase should be con-
sidered as a marker of circadian phase, and it has been shown to correlate well with other cir-
cadian phase parameters such as the start of melatonin production [24–27]. Functional
damage of ipRGCs might lead to misalignment of the circadian clock to light resulting in either
freerunning patterns of sleep and wakefulness, or to modulations of the direct effects of light
on sleep and wakefulness [4,28]. The intrinsic period of the circadian clock in humans differs
between individuals and is on average a little bit longer than 24 hours [13,29–31]. The
entrained phase of the circadian pacemaker is dependent on the intrinsic period showing a
later sleep phase with longer intrinsic period [25,32–35]. Consequently, damage to the ipRGCs
in glaucoma might result in a delay of the mean MSFsc and an increase in sleep phase variabil-
ity. A delay and an increase in variability in activity onsets has indeed been found in animal
studies to glaucoma [36,37]. More variability in waking time was also observed in a diverse
group of young subjects with an optic nerve disease, including some patients with glaucoma
[38]. Intriguingly, studies to the entrained circadian phase of glaucoma patients appear to be
completely lacking.
The aim of this study was to compare chronotype as a measure of circadian phase between
glaucoma patients and healthy subjects. For this purpose, we performed a questionnaire study
with the Munich ChronoType Questionnaire (MCTQ) and determined the chronotype distri-
bution amongst a large group of glaucoma patients and controls.
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Methods
Study population and data acquisition
The MCTQ was sent by mail to 221 glaucoma patients (cases) with open-angle glaucoma
(primary or related to pseudoexfoliation or pigment dispersion). Patients were participants
in the Groningen Longitudinal Glaucoma Study (GLGS). The GLGS is an observational
cohort study conducted in the University Medical Center Groningen [39]. We approached
those participants who were still visiting our clinic, were followed with standard automated
perimetry (SAP; Humphrey field analyzer [HFA] 30–2 SITA; Carl Zeiss Meditec AG, Jena,
Germany), and had a reproducible visual field defect on SAP in at least one eye, defined as a
scotoma according to the LTG-P criterion [40] or a glaucoma hemifield test ‘outside normal
limits’. For descriptive statistics, the patients were stratified into early, moderate, or severe
glaucoma, using the mean deviation (MD) value of the better eye (eye with the higher MD
value) [41–46] corresponding to the most recent visual field test. As cut-off points between
the strata we employed -6 and -12 dB. For the classification, we used the most recent visual
field test result.
Two questionnaires were sent to each patient; they were asked to complete one question-
naire and to give the other to their spouse, neighbor, friend, etc. (no consanguinity), who
served as control [47]. Patients and controls were explicitly asked to fill in the questionnaire
independently. As the number of returned patient questionnaires exceeded the number of
control questionnaires (in 30% only the patient questionnaire was returned), additional con-
trols were recruited from a recent case-control studies conducted in our department [48].
Controls were asked to confirm that they (1) did not have relatives with high eye pressure or
glaucoma and (2) did not receive regular checkups by an ophthalmologist for high eye pressure
or glaucoma. In this way we assured a glaucoma prevalence of<1% amongst the controls [49].
A secondary control group was obtained by taking an age- and gender-matched sample
from 17073 subjects who participated in an internet-based citizen-science project. Details of
the study protocol and the results for the first 5055 subjects have been described before [50].
From these subjects, only their age and gender was known.
The ethics board of the University Medical Center Groningen (UMCG) approved the study
protocol (METc 2014.338). All participants provided written informed consent. The study fol-
lowed the tenets of the Declaration of Helsinki.
Data analysis
Shift workers and participants who woke-up due to an alarm clock on days off were excluded
from the analyses. The study population was described using descriptive statistics. Univariable
comparisons between cases and controls (from the primary control group) were made with a
t-test or Mann-Whitney test, depending on the distribution, for continuous variables; for pro-
portions we used a Chi-square test with Yates correction.
For questions regarding bedtime information on days off (Q1-Q8; see Results section), the
mean and standard deviation (SD) were determined for glaucoma patients and controls (from
the primary control group). Sleep onset was calculated as the sum of the point of time to get
ready to fall asleep, and the length of time needed to actually fall asleep (Q2 and Q3). The sleep
duration was defined as the difference between the calculated sleep onset and the wake-up
time (Q4). The mid-sleep on days off (MSF) was defined as the midpoint between sleep onset
and wake-up time. When the sleep duration during the workweek was shorter compared to
that of days off, we corrected the MSF (MSFsc) for workweek accumulated sleep debt [24]. We
compared means with a Welch’s t-test (unlike the default t-test, this test allows for unequal
Chronotyping glaucoma patients
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variances) and distributions with an F-test. For MSFsc, we also performed a comparison after
stratification to disease severity (early glaucoma: MD of better eye above -6 dB; moderate glau-
coma: MD between -6 and -12 dB; severe glaucoma: MD below -12 dB) using a Welch F-test
(an alternative to one-way analysis of variance (ANOVA) that does not assume the variances
to be equal) to compare means and F-tests to compare variances. If significant differences
between disease severity strata were found, we also performed a trend analysis. Analyzes were
performed using R (version 3.4.2; R Foundation for Statistical Computing, Vienna, Austria). A
P value of 0.05 or less was considered statistically significant.
From the citizen-science project participants (n = 17073), we selected all participants with
age 42 (age of youngest glaucoma patient) and above (n = 4571; median age 51, range 42–100,
interquartile range [IQR] 46–57)). From this subset, we took an age- and gender-matched
sample (matched to the glaucoma patients) using propensity score matching in R (matchit
with method = "nearest", discard = "both", and ratio = 1). This sampling was repeated 30 times,
yielding a mean MSFsc with corresponding confidence interval (CI).
Results
We retrieved 178 questionnaires from 221 glaucoma patients (response rate 81%) and 182
questionnaires from controls. After exclusion of shift workers and participants who woke-up
due to an alarm clock on days off, 159 glaucoma patients and 163 controls remained. Table 1
shows the characteristics of the study population. The group of glaucoma patients was older
and consisted of fewer females, compared to the controls. Most of the patients had early glau-
coma (63%); about one-third had either moderate (16%) or severe (21%) glaucoma in the bet-
ter eye.
Table 2 presents the results from the MCTQ (A) and the corresponding calculated variables
(B). We used the 24-hour clock notation for questions regarding time (23:30 is half past eleven
p.m.) and duration (0:30 is 30 minutes, i.e., 0.5 hours). The original questions (Table 2A)
revealed no major differences in average sleep timing parameters between the groups; how-
ever, for bedtime (Q1), time to get ready to fall asleep (Q2), sleep latency (Q3), minutes to get
up after waking (Q5), and hours spent outside (Q8), the variability appeared to be larger in the
glaucoma patients than in the controls, although only for Q5 a Bonferroni corrected P value of
0.006 (0.05/8) was reached. Fig 1 presents the distribution of chronotypes (MSFsc). The mean
and distribution of the MSFsc were not significantly different between glaucoma patients and
controls (Table 2B; P = 0.21 for mean and P = 0.15 for variability). Table 3 shows the corre-
sponding results after stratification to disease severity. Because of missing data (reported in the
last column of Table 2), the total number of glaucoma patients and controls in Table 3 differs
Table 1. Characteristics of the study population.
Glaucoma patients (n = 159) Controls (n = 163) P value Missing (%)
Age (year; mean [SD]) 72.2 (10.0) 65.9 (10.5) <0.001 0.0
Gender, female, n (%) 77 (48%) 105 (64%) 0.005 0.0
BMI (kg/m2; mean [SD]) 26.2 (4.7) 26.1 (4.9) 0.81 5.3
Smoker, n (%) 15 (9.4%) 16 (9.8%) 1.0 0.0
Working days per week (days; median [IQR]) 0 (0 to 0) 0 (0 to 3) 0.004 5.3
HFA MD of the better eye (dB; median [IQR]) -4.5 (-10.7 to -1.9) NA NA 0.0
SD = standard deviation; BMI = body mass index; IQR = interquartile range; HFA MD = mean deviation of Humphrey Field Analyzer; NA = not applicable.
https://doi.org/10.1371/journal.pone.0214046.t001
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slightly from the total numbers in Tables 1 and 2. The mean MSFsc did not differ between the
groups (P = 0.62). The variability of MSFsc was significantly larger for the patients with severe
glaucoma compared to the controls (P = 0.023); the variability of MSFsc showed a non-signifi-
cant trend to increase with disease severity (P = 0.057).
Table 2. MCTQ derived bedtime information on days off.
Glaucoma patients (n = 159) Mean (SD) Controls (n = 163) Mean (SD) P value For Mean (SD) Missing (%)
A. Questionnaire results
Q1. I go to bed at . . . o’clock 23:24 (0:55) 23:27 (0:46) 0.56
(0.013)
5.6
Q2. I actually get ready to fall asleep at . . . o’clock 23:42 (0:53) 23:48 (0:45) 0.36
(0.025)
7.5
Q3. I need . . . minutes to fall asleep 0:16 (0:15) 0:16 (0:17) 0.71
(0.036)
9.6
Q4. I wake up at . . . o’clock 7:25 (1:11) 7:37 (1:07) 0.13
(0.23)
7.1
Q5. After . . . minutes I get up 0:29 (0:39) 0:25 (0:27) 0.24
(<0.001)
6.8
Q6. After . . . minutes I feel awake 0:07 (0:13) 0:07 (0:14) 0.81
(0.29)
7.5
Q7. The quality of my nightrest (1–10) 6.7 (1.7) 6.9 (1.6) 0.37
(0.29)
4.3




Sleep onset 23:58 (0:56) 00:04 (0:49) 0.32
(0.046)
11.2
Sleep duration 7:28 (1:12) 7:33 (1:08) 0.58
(0.28)
12.1




The 24-hour clock notation is used for questions regarding time (23:30 is half past eleven p.m.) and duration (0:30 is 30 minutes, i.e., 0.5 hours).
� = age- and gender-adjusted P value 0.91.
https://doi.org/10.1371/journal.pone.0214046.t002
Fig 1. Histogram with frequency as a function of chronotype (MSFsc) for patients with glaucoma (A) and controls (B).
https://doi.org/10.1371/journal.pone.0214046.g001
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The mean MSFsc of the secondary control group was 3:50 (95% CI 3:48 to 3:52). Compared
to this control group, the mean MSFsc of the glaucoma patients was significantly earlier (differ-
ence 0:10; P = 0.024). Mean MSFsc did not differ between the control groups (P = 0.42).
Discussion
Glaucoma appears not to have a substantial effect on the mean chronotype (MSFsc). Possibly,
MSFsc is slightly advanced in glaucoma patients and—related to that—has an increased its
variability.
The chronotype as a function of age in healthy subjects has been investigated in a large
open study of around 25,000 subjects from Germany and Switzerland. In agreement with our
study, the MSFsc in subjects older than 50 years of age was between 3 and 4 AM, with a stan-
dard deviation of 1 hour [24]. Although chronotype was not assessed in glaucoma before,
some studies that included glaucoma patients presented data on sleep timing. In agreement
with our findings, they showed a general similarity between glaucoma patients and controls
[18,22,51]. Albeit no differences in sleep timing, a lower sleep efficiency (the amount of actual
sleep during the night) and quality have been reported in glaucoma patients [18–22]. Of note,
the previous studies did not analyze working days and days off separately. Since the sleep pat-
tern on work days significantly differs from the sleep pattern on days off, the comparison to
our study is limited [23].
A limitation of the current study is that the glaucoma patients and controls (from the pri-
mary control group) significantly differed with respect to age and gender. However, the change
of MSFsc with age above 45 years of age is small, and gender differences also appear only signif-
icant below 45 years of age. Therefore, age and gender differences between our groups are pre-
sumably hardly relevant [24]. To confirm this, we adjusted the MSFsc for age and gender and
still did not find a difference between glaucoma patients and controls (P = 0.91; footnote to
Table 2). Essentially one control was recruited per patient, being the spouse or a neighbor or
friend (no consanguinity). An advantage of this approach is that it may control for external
factors that influence sleep behavior. A possible drawback is synchronization of the chrono-
types of people living together. A small to moderate correlation (0.25–0.40) between chrono-
types in husband-wife relationships has been found, which was more the result of assortative
mating than caused by cohabitation during marriage [52,53].To explore potential biases
related to our recruitment method, we recruited a secondary control group from an indepen-
dent source. This control group was age and gender matched to the patients and came from
the same latitude and longitude. No significant differences in MSFsc were found between the
control groups. A strength of this study is that it is the first study that investigated chronotype
as a measure of circadian phase in a large group of glaucoma patients, and compared it to con-
trols. We did not screen for the presence of other eye diseases but rather assumed that they
Table 3. MSFsc mean and standard deviation as a function of disease severity.
n MSFsc mean P value
� MSFsc SD P value
†
Controls 146 3:47 0.62 0:48
Early glaucoma 88 3:40 0:49 0.40
Moderate glaucoma 21 3:45 0:55 0.20
Severe glaucoma 23 3:33 1:05 0.023
SD = standard deviation;
� = Welch F-test;
† = significance of MSFsc SD compared to the controls.
https://doi.org/10.1371/journal.pone.0214046.t003
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would be equally distributed amongst the groups. In this way we aimed for a realistic sample
of elderly rather than super normals.
Our results appear to be in agreement with studies on the ipRGC-mediated pupil response,
which has repeatedly been found to be similar in early glaucoma compared to controls, while
differences did appear in more advanced disease [54–56]. There are several hypotheses why
there is no clear difference in chronotype distribution between early and moderate glaucoma
patients and controls. First, it is not clear if the ipRGCs disappear in parallel with the image-
forming RGCs, or only in advanced disease [57–60]. Second, a lower number of ipRGCs does
not necessarily mean less effect—the dose-response curve might be highly nonlinear. A mouse
study found that even with the loss of 83% of the ipRGCs, a normal ipRGC-mediated pupil
constriction could still be obtained [4]. Moreover, a hamster study reported that the circadian
system attained saturation at lower irradiance levels than those required to induce pupil con-
striction [61]. Interestingly, our results hint towards an increase in the variability of the MSFsc
in patients with severe glaucoma, and possibly some advancement of the mean MSFsc. If con-
firmed in other studies, this suggests that some patients have a more advanced sleep phase,
with or without a more delayed sleep phase in others. The delay might be explained by the
hypothesized change related to the longer than 24-hour intrinsic period. More advanced sleep
phases may be explained by some people having an intrinsic period that is shorter than 24
hours and who at the same time suffer from a lack of delaying evening light or miss the acute
effects of light keeping them awake [11,62]. An increase in artificial light and the adaptational
properties of the non-image forming system might compensate for a change in the MSFsc
[63,64]. Whatever the mechanisms involved, individual shifts of the MSFsc to either way will
contribute to an increase in variability.
In conclusion, no clear changes were found in the chronotype as determined by sleep phase
in patients with glaucoma, especially not in early and moderate glaucoma. In severe glaucoma,
chronotype variability seems to increase, possibly alongside some advancement. A more severe
loss of ipRGCs in the human retina of glaucoma patients probably results in more difficulties
with stable entrainment either due to a reduction in the phase shifting effects of light on the
clock or to less influence of light on brain areas directly involved in sleep-wake regulation
itself. Future studies might focus on a more in-depth analysis of the circadian clock in severe
glaucoma and related disturbance of their quality of life.
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